Clinical Trials · NCT00765999

An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation

Name: An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Linaclotide

Phase: Phase 3
Recruitment status: Completed
Sponsor: Forest Laboratories
Enrollment: 1,559
Start date: Oct 2008
Locations: 118 sites, United States, Canada
Primary endpoint: Number of Participants With at Least One Treatment-Emergent Adverse Events (TEAEs)

View Linaclotide compound reference